Familial migraine with vertigo: No mutations found in CACNA1A

American Journal of Medical Genetics

Volumn 79, Issue 2, 1998, Pages 148-151

  Kim, Ji Soo ^a   Yue, Qing ^a   Jen, Joanna C ^a   Nelson, Stanley F ^a   Baloh, Robert W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Genetics; Migraine; Vertigo

Indexed keywords

ION CHANNEL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILIAL DISEASE; FAMILY STUDY; FEMALE; GENE MUTATION; HUMAN; INNER EAR; INTRON; MALE; MIGRAINE; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE STRAND CONFORMATION POLYMORPHISM; VERTIGO;

ADULT; CALCIUM CHANNELS; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; MUTATION; PEDIGREE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TRINUCLEOTIDE REPEATS; VERTIGO;

EID: 0032169042     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19980901)79:2<148::AID-AJMG11>3.0.CO;2-J     Document Type: Article

References (24)

1. Baloh RW, Foster CA, Yue Q, Nelson SF (1996): Familial migraine with vertigo and essential tremor. Neurology 46:458-460.
2. Baloh RW, Jacobson K, Fife T (1994): Familial vestibulopathy: a new dominantly inherited syndrome. Neurology 44:20-25.
3. Baloh RW, Yue Q, Furman JM, Nelson SF (1997): Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p. Ann Neurol 41:8-16.
4. Buchwalder A, Welch SK, Peroutka SJ (1996): Exclusion of S-HT- and 5-HT2c receptor genes as candidate genes for migraine. Headache 36:254-258.
5. Bulman DE (1997): Phenotype variation and newcomers in ion channel disorders. Hum Mol Genet 10:1679-1685.
6. Hakkarainen H, Allonen H (1982): Ergotamine vs. metoclopramide vs. their combination in acute migraine attacks. Headache 22:10-12.
7. Hann J, Terwindt GM, Ophoff RA, Bos PLJM, Frants RR, Ferrari MD (1995): Is familial hémiplégie migraine a hereditary form of basilar migraine? Cephalalgia 15:477-481.
8. Headache Classification Committee of the International Headache Society (1988): Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8(suppl 7):l-96.
9. Hovatta I, Kallela M, Fräkkilä M, Peltonen L (1994): Familial migraine: exclusion of the susceptibility gene from the reported locus of familial hémiplégie migraine on 19p. Genomics 23:707-709.
10. Kayan A, Hood JD (1984): Neuro-otological manifestations of migraine. Brain 107:1123-1142.
11. May A, Ophoff RA, Terwindt GM, Urban C, van Eijk R, Haan J, Diener HC, Lindhout D, Frants RR, Sandkuijl LA, Ferrari MD (1995): Familial hémiplégie migraine locus on 19pl3 is involved in the common forms of migraine with and without aura. Hum Genet 96:604-608.
12. Mon Y, Friedrich T, Kim MS, Atsushi M, Nakai J, Ruth P, Bosse E, Hofmann F, Flockerzi V, Furuichi T, Mikoshiba K, Imoto K, Tanabe T, Numa S (1991): Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature 350:398-102.
13. Nyholt DR, Curtain RP, Gaffney PT, Brimage P, Goadsby PJ, Griffiths LR (1996): Migraine association and linkage analyses of the human 5hydroxytryptamine (5HT2A' receptor gene. Cephalalgia 16:463-467.
14. Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Huffman SMG, Lamerdin JE, Mohrenweiser HW, Bulman DE, Ferrari M, Haan J, Lindhout D, van Ommen GB, Hofker MH, Ferrari MD, Frants RR (1996): Familial hémiplégie migraine and episodic ataxia type-2 are i caused by mutations in the CA2 channel gene CACNL1A4. Cell 87:543-552.
15. Orita M, Suzuki Y, Sekiya T, Haayshi K (1989): Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874-879.
16. Paterna S, Pasquale PD, Cottone C, Seidita G, Cardinale A, Parrinello G, Ferrari G, Licata G (1997): Migraine without aura and ACE-gene deletion polymorphism: Is there a correlation? Preliminary findings. Cardiovasc Drug Ther 11:603-604.
17. Peroutka SJ, Wilhoit T, Jones K (1997): Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) Ncol alleles. Neurology 49:201-206.
18. Ptâcek LJ (1997): Channelopathies: ion channel disorders of muscle as paradigm for paroxysmal disorders of the nervous system. Neuromusc Disord 7:250-255.
19. Ravnik-Glavak M, Glavac M, Dean M (1994): Sensitivity of single-strand conformation polymorphism and heteroduplex method for mutation detection in the cystic fibrosis gene. Hum Mol Genet 3:801-807.
20. Russell MB, Hilden J, Sorensen SA, Olesen J (1993): Familial occurrence of migraine without aura and migraine with aura. Neurology 43:13691373.
21. Sicuteri F (1997): Dopamine, the second putative protagonist in headache. Headache 17:129-131.
22. Volsen SG, Day NC, McCormack AL, Smith W, Craig PJ, Beattie R, Ince PGB, Shaw PJ, Ellis SB, Gillespie A, Harpold MM, Lodge D (1995): The expression of neuronal voltage-dependent calcium channels in human cerebellum. Mol Brain Res 34:271-282.
23. Yue Q, Jen JC, Nelson SF, Baloh R\V (1997): Progressive ataxia due to a missense mutation in a calcium-channel gene. Am J Hum Genet 61:1078-1087.
24. Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW, Amos C, Dobyns WB, Subramony SH, Zoghbi HY, Lee CC (1997): Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansion in the oA-voltage-dependent calcium channel. Nat Genet 15:62-69.